Australia markets closed

Catalent Inc (0C8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
61.87+10.42 (+20.25%)
As of 10:31AM CET. Market open.
Full screen
Previous close51.45
Bid0.00 x 300000
Ask0.00 x 300000
Day's range53.00 - 61.87
52-week range39.41 - 112.06
Avg. volume3
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast

    SOMERSET, N.J., January 20, 2023--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it will release financial results for the second quarter of fiscal year 2023 ended December 31, 2022, before the market open on Tuesday, February 7, 2023. The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET

  • Business Wire

    Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader

    SOMERSET, N.J., January 17, 2023--Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader

  • PR Newswire

    Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it has entered into a multi-year supply and services agreement with Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide. Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laborator